A
Autolus Therapeutics plc
AUTL
4.52000
USD
-0.17
(-3.62%)
مغلق
حجم التداول
68,143
الربح لكل سهم
0
العائد الربحي
0
P/E
-3
حجم السوق
933,991,544
العنوان: Autolus Therapeutics plc
القطاع: Healthcare
الصناعة: Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3,AUTO5, AUTO6, AUTO7 & AUTO8.